AnorMED Inc. — Investor Relations & Filings
AnorMED Inc. was a chemistry-based biopharmaceutical company focused on the discovery, research, and development of small molecule therapeutics. The company specialized in applying chemistry, biochemistry, and biology to create novel treatments, primarily targeting serious diseases such as cancer and HIV. A key compound in its portfolio, AMD-3100, reached Phase III clinical development. AnorMED Inc. ceased independent operations in October 2006 following its acquisition by Genzyme Corporation for approximately US$584 million.
Recent filings
No filings indexed yet
We are still gathering filings for AnorMED Inc.. .
No filings match the current filters
Try clearing the filters, or .
Market data
Market data not available
Price history
Peer group · Research and experimental development on natural sciences and engineering
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
IXICO PLC
Provides AI-driven neuroimaging and data analytics for neur…
|
IXI | GB | Professional, scientific and te… |
|
Jade Biosciences, Inc.
A clinical-stage biotech developing therapies for autoimmun…
|
JBIO | US | Professional, scientific and te… |
|
Jasper Therapeutics, Inc.
A clinical-stage biotech developing therapies targeting mas…
|
JSPR | US | Professional, scientific and te… |
|
Jeevan Scientific Technology Limited
A CRO providing Phase I-IV trials, BA/BE research, and phar…
|
538837 | IN | Professional, scientific and te… |
|
J. Molner AS
A CDRO developing generic sterile injectable and dermatolog…
|
JML | EE | Professional, scientific and te… |
|
JOINN Laboratories (China) Co., Ltd.
Comprehensive CRO providing end-to-end preclinical drug dis…
|
6127 | HK | Professional, scientific and te… |
|
JOINN LABORATORIES (CHINA) CO., LTD.
A CRO specializing in non-clinical safety assessment and ph…
|
603127 | CN | Professional, scientific and te… |
|
Kadimastem Ltd.
Clinical-stage cell therapy company developing treatments f…
|
KDST | IL | Professional, scientific and te… |
|
KAINOS MEDICINE, INC.
Develops small molecule therapeutics for neurodegenerative,…
|
284620 | KR | Professional, scientific and te… |
|
Kairos Pharma, LTD.
Develops oncology therapies targeting drug resistance and i…
|
KAPA | US | Professional, scientific and te… |
AnorMED Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/44676/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=44676 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=44676 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=44676 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 44676}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for AnorMED Inc. (id: 44676)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.